Epstein-Barr virus EBNA2 directs doxorubicin resistance of B cell lymphoma through CCL3 and CCL4-mediated activation of NF-κB and Btk

Oncotarget (2017) - Comment
pubmed: 28036258 doi: 10.18632/oncotarget.14243 issn: 1949-2553

Joo Hyun Kim, Won Seog Kim, Jung Yong Hong, Kyungju Ryu, Seok Jin Kim, Chaehwa Park